Cargando…
Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis
BACKGROUND & AIMS: Benzodiazepines are associated with an increased risk of harm in patients with cirrhosis. However, stopping benzodiazepines must be done with care to avoid withdrawal or other unintended consequences. The impact of deprescribing on patients with cirrhosis is unknown. METHODS:...
Autores principales: | Tapper, Elliot B., Zhao, Zhe, Winder, G. Scott, Parikh, Neehar D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052149/ https://www.ncbi.nlm.nih.gov/pubmed/35493764 http://dx.doi.org/10.1016/j.jhepr.2022.100478 |
Ejemplares similares
-
Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
por: Weersink, Rianne Antoinet, et al.
Publicado: (2022) -
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
por: Tapper, Elliot B, et al.
Publicado: (2018) -
Association between widespread pain and associated symptoms in patients with cirrhosis
por: Holman, Alexis, et al.
Publicado: (2023) -
Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis
por: Foster, Chelsey, et al.
Publicado: (2020) -
Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)